Ingavirin

Ingavirin
Identifiers
	IUPAC name 5-[2-(1H-imidazol-5-yl)ethylamino]-5-oxopentanoic acid;
CAS Number	219694-63-0;
PubChem CID	9942657;
DrugBank	DB11944;
ChemSpider	8118269;
UNII	3CM03MUJ69;
KEGG	C11250;
ChEMBL	ChEMBL4297291;
CompTox Dashboard (EPA)	DTXSID90433141 ;
ECHA InfoCard	100.234.559
Chemical and physical data
Formula	C10H15N3O3
Molar mass	225.248 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1=C(NC=N1)CCNC(=O)CCCC(=O)O;
	InChI InChI=1S/C10H15N3O3/c14-9(2-1-3-10(15)16)12-5-4-8-6-11-7-13-8/h6-7H,1-5H2,(H,11,13)(H,12,14)(H,15,16); Key:KZIMLUFVKJLCCH-UHFFFAOYSA-N;

Ingavirin (Ingamine, Vitavirin) is an antiviral drug developed in Russia, with activity against respiratory viruses such as influenza, COVID-19, and human metapneumovirus.^[1]^[2]^[3]^[4]^[5]

References

^ Kolobukhina LV, Merkulova LN, Shchelkanov MI, Burtseva EI, Isaeva EI, Malyshev NA, et al. (2009). "[Efficacy of ingavirin in adults with influenza]". Terapevticheskii Arkhiv. 81 (3): 51–54. PMID 19459424.
^ Isaeva EI, Nebol'sin VE, Kozulina IS, Morozova OV (2012). "[In vitro investigation of the antiviral activity of Ingavirin against human metapneumovirus]". Voprosy Virusologii. 57 (1): 34–38. PMID 22624471.
^ Shul'diakov AA, Liapina EP, Kuznetsov VI (2013). "[Current principles in the chemoprophylaxis of acute respiratory viral infections]". Terapevticheskii Arkhiv. 85 (11): 27–33. PMID 24432596.
^ Malík I, Kovac G, Padrtova T, Hudecova L (2020). "Ingavirin might be a promising agent to combat Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2)". Ceska a Slovenska Farmacie. 69 (3): 107–111. doi:10.36290/csf.2020.017. PMID 32972153.
^ Zyryanov SK, Butranova OI, Gaidai DS, Kryshen KL (January 2021). "[Pharmacotherapy for acute respiratory infections caused by influenza viruses: current possibilities]". Terapevticheskii Arkhiv. 93 (1): 114–124. doi:10.26442/00403660.2021.01.200551. PMID 33720636.